Allison L Richards

6PUBLICATIONS
105CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

|Jun 17, 2026
Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|Sep 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.

Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley

|Mar 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.

Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting

|Oct 13, 2017
Environmental perturbations lead to extensive directional shifts in RNA processing.

Allison L Richards, Donovan Watza, Anthony Findley

Pageof 1

Frequent Collaborators

3 joint publications

Mark T A Donoghue

2 joint publications

Samuel Singer

2 joint publications

Aimee M Crago

2 joint publications

Ciara M Kelly